"Ranolazine/administration and dosage"[MeSH] - Search Results

Year	Number of Results
2014	3
2015	13
2016	6
2017	4
2018	8
2019	7
2020	5
2021	4
2024	0

1

Ranolazine Therapy in Cardiac Arrhythmias.

Pulford BR, Kluger J. Pulford BR, et al. Pacing Clin Electrophysiol. 2016 Sep;39(9):1006-15. doi: 10.1111/pace.12905. Epub 2016 Jul 23. Pacing Clin Electrophysiol. 2016. PMID: 27358212 Review.

2

Antiarrhythmic effects of ranolazine used both alone for prevention of atrial fibrillation and as an add-on to intravenous amiodarone for its pharmacological cardioversion: a meta-analysis.

De Vecchis R, Ariano C, Giasi A, Cioppa C. De Vecchis R, et al. Minerva Cardioangiol. 2018 Jun;66(3):349-359. doi: 10.23736/S0026-4725.17.04349-3. Epub 2017 May 10. Minerva Cardioangiol. 2018. PMID: 28497941 Review.

3

Novel Use of Ranolazine as an Antiarrhythmic Agent in Atrial Fibrillation.

White CM, Nguyen E. White CM, et al. Ann Pharmacother. 2017 Mar;51(3):245-252. doi: 10.1177/1060028016673073. Epub 2016 Oct 6. Ann Pharmacother. 2017. PMID: 27758968 Review.

4

Persistence of a Posaconazole-Mediated Drug-Drug Interaction With Ranolazine After Cessation of Posaconazole Administration: Impact of Obesity and Implications for Patient Safety.

Chow CR, Harmatz JS, Ryan MJ, Greenblatt DJ. Chow CR, et al. J Clin Pharmacol. 2018 Nov;58(11):1436-1442. doi: 10.1002/jcph.1257. Epub 2018 May 11. J Clin Pharmacol. 2018. PMID: 29749631

5

Long-term administration of ranolazine attenuates diastolic dysfunction and adverse myocardial remodeling in a model of heart failure with preserved ejection fraction.

De Angelis A, Cappetta D, Piegari E, Rinaldi B, Ciuffreda LP, Esposito G, Ferraiolo FA, Rivellino A, Russo R, Donniacuo M, Rossi F, Urbanek K, Berrino L. De Angelis A, et al. Int J Cardiol. 2016 Aug 15;217:69-79. doi: 10.1016/j.ijcard.2016.04.168. Epub 2016 May 12. Int J Cardiol. 2016. PMID: 27179211

6

Ranolazine for stable angina pectoris.

Salazar CA, Basilio Flores JE, Veramendi Espinoza LE, Mejia Dolores JW, Rey Rodriguez DE, Loza Munárriz C. Salazar CA, et al. Cochrane Database Syst Rev. 2017 Feb 8;2(2):CD011747. doi: 10.1002/14651858.CD011747.pub2. Cochrane Database Syst Rev. 2017. PMID: 28178363 Free PMC article. Review.

7

Ranolazine in the prevention and treatment of atrial fibrillation: A protocol for meta-analysis.

Yuan C, Luo W, Ren X, Ya M, Yan W, Hui Q. Yuan C, et al. Medicine (Baltimore). 2021 Apr 23;100(16):e25437. doi: 10.1097/MD.0000000000025437. Medicine (Baltimore). 2021. PMID: 33879675 Free PMC article.

8

Ranolazine for the treatment of atrial fibrillation.

Rosa GM, Dorighi U, Ferrero S, Brunacci M, Bertero G, Brunelli C. Rosa GM, et al. Expert Opin Investig Drugs. 2015 Jun;24(6):825-36. doi: 10.1517/13543784.2015.1036984. Epub 2015 Apr 15. Expert Opin Investig Drugs. 2015. PMID: 25872749 Review.

9

Pre- and Delayed Treatments With Ranolazine Ameliorate Ventricular Arrhythmias and Nav1.5 Downregulation in Ischemic/Reperfused Rat Hearts.

Wei X, Zhu A, Zhang Y, Yao S, Mao W. Wei X, et al. J Cardiovasc Pharmacol. 2016 Oct;68(4):269-279. doi: 10.1097/FJC.0000000000000412. J Cardiovasc Pharmacol. 2016. PMID: 27228311

10

Ranolazine protects against diabetic cardiomyopathy by activating the NOTCH1/NRG1 pathway.

Chen X, Ren L, Liu X, Sun X, Dong C, Jiang Y, Qin Y, Qu H, Jiao J, Wang S, Bai Y, Yang B. Chen X, et al. Life Sci. 2020 Nov 15;261:118306. doi: 10.1016/j.lfs.2020.118306. Epub 2020 Aug 21. Life Sci. 2020. PMID: 32828943

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

41 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year